Intrinsic and Extrinsic Regulation of Innate Immune Receptors

키워드

참고문헌 (137)

1. Janeway CA Jr, "The immune system evolved to discriminate infectious nonself from noninfectious self", Immunol Today, 13, pp.11~16 (1992)
2. Medzhitov R, "Innate immunity: impact on the adaptive immune response", Curr Opin Immunol, 9, pp.4~9 (1997)
3. Medzhitov R, "Decoding the patterns of self and nonself by the innate immune system", Science, 296, pp.298~300 (2002)
4. Medzhitov R, "Toll-like receptors and innate immunity", Nat Rev Immunol, 1, pp.135~145 (2001)
5. Akira S, "Toll-like receptors: critical proteins linking innate and acquired immunity", Nat Immunol, 2, pp.675~680 (2001)
6. Hoffmann JA, "The immune response of Drosophila", Nature, 426, pp.33~38 (2003)
7. Meylan E, "Toll-like receptors and RNA helicases: two parallel ways to trigger antiviral responses", Mol Cell, 22, pp.561~569 (2006)
8. Yoneyama M, "RNA recognition and signal transduction by RIG-I-like receptors", Immunol Rev, 227, pp.54~65 (2009)
9. Lee JY, "Modulation of pattern recognition receptor-mediated inflammation and risk of chronic diseases by dietary fatty acids", NUTRITION REVIEWS, 68, pp.38~61 (2010), BLACKWELL PUBLISHING
10. O’Neill LA, "Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer", Pharmacol Rev, 61, pp.177~197 (2009)
11. Joo Y. Lee, "The Modulation of Inflammatory Gene Expression by Lipids: Mediation through Toll-like Receptors", Molecules and Cells, 21(2), pp.174~185 (2006), 한국분자세포생물학회
12. Lemaitre B, "The dorsoventral regulatory gene cassette spätzle", Toll, Cell, pp.1996, 86[DOI]
13. Medzhitov R, "A human homologue of the Drosophila Toll protein signals activation of adaptive immunity", Nature, 388, pp.394~397 (1997)
14. Akira S, "Pathogen recognition and innate immunity", Cell, 124, pp.783~801 (2006)
15. Kawai T, "The roles of TLRs, RLRs and NLRs in pathogen recognition", Int Immunol, 21, pp.317~337 (2009)
16. Poltorak A, "Defective LPS signaling in C3H", HeJ and C57BL, Science, pp.1998, 282[DOI]
17. Hoshino K, "Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product", J Immunol, 162, pp.3749~3752 (1999)
18. Miyake K, "Roles for accessory molecules in microbial recognition by Toll-like receptors", J Endotoxin Res, 12, pp.195~204 (2006)
19. Park BS, "The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex", NATURE, 458, pp.1191~U130 (2009), NATURE PUBLISHING GROUP
20. Gazzinelli RT, "Role of the Toll", interleukin-1 receptor signaling pathway in host resistance and pathogenesis during infection with protozoan parasites, 2004, pp.201, 9~25
21. Burzyn D, "Toll-like receptor 4-dependent activation of dendritic cells by a retrovirus", J Virol, 78, pp.576~584 (2004)
22. Kurt-Jones EA, "Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus", Nat Immunol, 1, pp.398~401 (2000)
23. Ohashi K, "Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex", J Immunol, 164, pp.558~561 (2000)
24. Asea A, "Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4", J Biol Chem, 277, pp.15028~15034 (2002)
25. Vabulas RM, "The endoplasmic reticulum-resident heat shock protein Gp96 activates dendritic cells via the Toll-like receptor 2", 4 pathway, 2002, pp.277, 20847~20853
26. Smiley ST, "Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4", J Immunol, 167, pp.2887~2894 (2001)
27. Termeer C, "Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4", J Exp Med, 195, pp.99~111 (2002)
28. Okamura Y, "The extra domain A of fibronectin activates Toll-like receptor 4", J Biol Chem, 276, pp.10229~10233 (2001)
29. Johnson GB, "Cutting edge: an endogenous pathway to systemic inflammatory response syndrome (SIRS)-like reactions through Toll-like receptor 4", J Immunol, 172, pp.20~24 (2004)
30. Vogl T, "Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock", Nat Med, 13, pp.1042~1049 (2007)
31. Miller YI, "Toll-like receptor 4-dependent and -independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages", Arterioscler Thromb Vasc Biol, 25, pp.1213~1219 (2005)
32. Lee JY, "Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4", J Biol Chem, 276, pp.16683~16689 (2001)
33. Stewart CR, "CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer", Nat Immunol, 11, pp.155~161 (2010)
34. Schmidt M, "Crucial role for human Toll-like receptor 4 in the development of contact allergy to nickel", Nat Immunol, 11, pp.814~819 (2010)
35. Wieland CW, "Non-mannose-capped lipoarabinomannan induces lung inflammation via toll-like receptor 2", Am J Respir Crit Care Med, 170, pp.1367~1374 (2004)
36. Campos MA, "Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite", J Immunol, 167, pp.416~423 (2001)
37. Ozinsky A, "The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors", Proc Natl Acad Sci U S A, 97, pp.13766~13771 (2000)
38. Bieback K, "Schneider-Schaulies J, Duprex WP, et al. Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling", J Virol, 76, pp.8729~8736 (2002)
39. Sato M, "Direct binding of Toll-like receptor 2 to zymosan, and zymosan-induced NF-kappa B activation and TNF-alpha secretion are down-regulated by lung collectin surfactant protein A", J Immunol, 171, pp.417~425 (2003)
40. Frasnelli ME, "TLR2 modulates inflammation in zymosan-induced arthritis in mice", Arthritis Res Ther, 7, pp.R370~R379 (2005)
41. Takeuchi O, "Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins", J Immunol, 169, pp.10~14 (2002)
42. Takeuchi O, "Discrimination of bacterial lipoproteins by Toll-like receptor 6", Int Immunol, 13, pp.933~940 (2001)
43. Hoebe K, "CD36 is a sensor of diacylglycerides", Nature, 433, pp.523~527 (2005)
44. Gantner BN, "Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2", J Exp Med, 197, pp.1107~1117 (2003)
45. Scheibner KA, "Hyaluronan fragments act as an endogenous danger signal by engaging TLR2", J Immunol, 177, pp.1272~1281 (2006)
46. Lee JY, "Saturated fatty acid activates but polyunsaturated fatty acid inhibits Toll-like receptor 2 dimerized with Toll-like receptor 6 or 1", J Biol Chem, 279, pp.16971~16979 (2004)
47. West XZ, "Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands", Nature, 467, pp.972~976 (2010)
48. 이유진, "The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5", NATURE, 410(6832), pp.1099~1103
49. Hawn TR, "A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to legionnaires’ disease", J Exp Med, 198, pp.1563~1572 (2003)
50. Gewirtz AT, "Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression", J Immunol, 167, pp.1882~1885 (2001)
51. Yarovinsky F, "TLR11 activation of dendritic cells by a protozoan profilin-like protein", Science, 308, pp.1626~1629 (2005)
52. Zhang D, "A toll-like receptor that prevents infection by uropathogenic bacteria", Science, 303, pp.1522~1526 (2004)
53. Wang T, "Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis", Nat Med, 10, pp.1366~1373 (2004)
54. Groskreutz DJ, "Respiratory syncytial virus induces TLR3 protein and protein kinase R, leading to increased double-stranded RNA responsiveness in airway epithelial cells", J Immunol, 176, pp.1733~1740 (2006)
55. Hardarson HS, "Toll-like receptor 3 is an essential component of the innate stress response in virus-induced cardiac injury", Am J Physiol Heart Circ Physiol, 292, pp.H251~H258 (2007)
56. Alexopoulou L, "Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3", Nature, 413, pp.732~738 (2001)
57. Kumar H, "Pathogen recognition in the innate immune response", Biochem J, 420, pp.1~16 (2009)
58. Moynagh PN, "TLR signalling and activation of IRFs: revisiting old friends from the NF-kappaB pathway", Trends Immunol, 26, pp.469~476 (2005)
59. Kawai T, "Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6", Nat Immunol, 5, pp.1061~1068 (2004)
60. Tabeta K, "Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection", Proc Natl Acad Sci U S A, 101, pp.3516~3521 (2004)
61. Krug A, "TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function", Immunity, 21, pp.107~119 (2004)
62. Krug A, "Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9", Blood, 103, pp.1433~1437 (2004)
63. Lund J, "Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells", J Exp Med, 198, pp.513~520 (2003)
64. Hemmi H, "A Toll-like receptor recognizes bacterial DNA", Nature, 408, pp.740~745 (2000)
65. Wagner H, "The immunogenicity of CpG-antigen conjugates", Adv Drug Deliv Rev, 61, pp.243~247 (2009)
66. Medzhitov R, "Recognition of microorganisms and activation of the immune response", Nature, 449, pp.819~826 (2007)
67. Nallagatla SR, "5’-triphosphate-dependent activation of PKR by RNAs with short stem-loops", Science, 318, pp.1455~1458 (2007)
68. Yoneyama M, "Shared and unique functions of the DExD", H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity, 2005, pp.175, 2851~2858
69. Kato H, "Cell type-specific involvement of RIG-I in antiviral response", Immunity, 23, pp.19~28 (2005)
70. Takahasi K, "Nonself RNA-sensing mechanism of RIG-I helicase and activation of antiviral immune responses", Mol Cell, 29, pp.428~440 (2008)
71. Kato H, "Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5", J Exp Med, 205, pp.1601~1610 (2008)
72. Ablasser A, "RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate", Nat Immunol, 10, pp.1065~1072 (2009)
73. Kawai T, "IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction", Nat Immunol, 6, pp.981~988 (2005)
74. Seth RB, "Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3", Cell, 122, pp.669~682 (2005)
75. Meylan E, "Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus", Nature, 437, pp.1167~1172 (2005)
76. Xu LG, "VISA is an adapter protein required for virus-triggered IFN-beta signaling", Mol Cell, 19, pp.727~740 (2005)
77. Sun Q, "The specific and essential role of MAVS in antiviral innate immune responses", Immunity, 24, pp.633~642 (2006)
78. Kumar H, "Essential role of IPS-1 in innate immune responses against RNA viruses", J Exp Med, 203, pp.1795~1803 (2006)
79. Oganesyan G, "Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response", Nature, 439, pp.208~211 (2006)
80. Kato H, "Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses", Nature, 441, pp.101~105 (2006)
81. Weber F, "Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses", J Virol, 80, pp.5059~5064 (2006)
82. Li X, "Structural basis of double-stranded RNA recognition by the RIG-I like receptor MDA5", Arch Biochem Biophys, 488, pp.23~33 (2009)
83. Martinon F, "Gout-associated uric acid crystals activate the NALP3 inflammasome", Nature, 440, pp.237~241 (2006)
84. Chamaillard M, "An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid", Nat Immunol, 4, pp.702~707 (2003)
85. Girardin SE, "Lessons from Nod2 studies: towards a link between Crohn’s disease and bacterial sensing", Trends Immunol, 24, pp.652~658 (2003)
86. Inohara N, "Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn’s disease", J Biol Chem, 278, pp.5509~5512 (2003)
87. Girardin SE, "A direct interaction between JNK1 and CrkII is critical for Rac1-induced JNK activation", EMBO J, 20, pp.3437~3446 (2001)
88. Pauleau AL, "Role of nod2 in the response of macrophages to toll-like receptor agonists", Mol Cell Biol, 23, pp.7531~7539 (2003)
89. Hsu YM, "The adaptor protein CARD9 is required for innate immune responses to intracellular pathogens", Nat Immunol, 8, pp.198~205 (2007)
90. O’Neill LA, "The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling", Nat Rev Immunol, 7, pp.353~364 (2007)
91. Li C, "Interactive sites in the MyD88 Toll", interleukin (IL) 1 receptor domain responsible for coupling to the IL1beta signaling pathway, 2005, pp.280, 26152~26159
92. Burns K, "MyD88, an adapter protein involved in interleukin-1 signaling", J Biol Chem, 273, pp.12203~12209 (1998)
93. Kawai T, "Unresponsiveness of MyD88-deficient mice to endotoxin", Immunity, 11, pp.115~122 (1999)
94. Yamamoto M, "Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway", Science, 301, pp.640~643 (2003)
95. Jiang Z, "CD14 is required for MyD88-independent LPS signaling", Nat Immunol, 6, pp.565~570 (2005)
96. Oshiumi H, "TIR-containing adapter molecule (TICAM)-2, a bridging adapter recruiting to toll-like receptor 4 TICAM-1 that induces interferon-beta", J Biol Chem, 278, pp.49751~49762 (2003)
97. Castrillo A, "Protein kinase Cepsilon is required for macrophage activation and defense against bacterial infection", J Exp Med, 194, pp.1231~1242 (2001)
98. Carty M, "The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling", Nat Immunol, 7, pp.1074~1081 (2006)
99. Kawai T, "Toll-like receptor and RIG-I-like receptor signaling", Ann N Y Acad Sci, 1143, pp.1~20 (2008)
100. Kawai T, "Signaling to NF-kappaB by Toll-like receptors", Trends Mol Med, 13, pp.460~469 (2007)
101. Saccani S, "p38-Dependent marking of inflammatory genes for increased NF-kappa B recruitment", Nat Immunol, 3, pp.69~75 (2002)
102. Chang L, "Mammalian MAP kinase signalling cascades", Nature, 410, pp.37~40 (2001)
103. Barton GM, "Toll-like receptor signaling pathways", Science, 300, pp.1524~1525 (2003)
104. Suzuki N, "Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4", Nature, 416, pp.750~756 (2002)
105. Chen ZJ, "Ubiquitin signalling in the NF-kappaB pathway", Nat Cell Biol, 7, pp.758~765 (2005)
106. Sato S, "Essential function for the kinase TAK1 in innate and adaptive immune responses", Nat Immunol, 6, pp.1087~1095 (2005)
107. Hemmi H, "The roles of two IkappaB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection", J Exp Med, 199, pp.1641~1650 (2004)
108. Balachandran S, "A FADD-dependent innate immune mechanism in mammalian cells", Nature, 432, pp.401~405 (2004)
109. Meylan E, "RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation", Nat Immunol, 5, pp.503~507 (2004)
110. Inohara N, "Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-kappaB", J Biol Chem, 274, pp.14560~14567 (1999)
111. Abbott DW, "The Crohn’s disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO", Curr Biol, 14, pp.2217~2227 (2004)
112. Kawai T, "TLR signaling", Cell Death Differ, 13, pp.816~825 (2006)
113. McWhirter SM, "IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts", Proc Natl Acad Sci U S A, 101, pp.233~238 (2004)
114. Joung SM, "Akt Contributes to Activation of the TRIF-Dependent Signaling Pathways of TLRs by Interacting with TANK-Binding Kinase 1", JOURNAL OF IMMUNOLOGY, 186(1), pp.499~507 (2011), AMER ASSOC IMMUNOLOGISTS
115. Sharma S, "Triggering the interferon antiviral response through an IKK-related pathway", Science, 300, pp.1148~1151 (2003)
116. gene induction by the interferon regulatory factor family of transcription factors, "Immunity", 2006, 349~360
117. Janssens S, "Regulation of interleukin-1- and lipopolysaccharide-induced NF-kappaB activation by alternative splicing of MyD88", Curr Biol, 12, pp.467~471 (2002)
118. Burns K, "Inhibition of interleukin 1 receptor", Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4, 2003, pp.197, 263~268
119. Janssens S, "MyD88S, a splice variant of MyD88, differentially modulates NF-kappaB- and AP-1-dependent gene expression", FEBS Lett, 548, pp.103~107 (2003)
120. Kinjyo I, "SOCS1", JAB is a negative regulator of LPS-induced macrophage activation, 2002, pp.17, 583~591
121. Bulut Y, "Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling", J Immunol, 167, pp.987~994 (2001)
122. Opipari AW Jr, "The A20 cDNA induced by tumor necrosis factor alpha encodes a novel type of zinc finger protein", J Biol Chem, 265, pp.14705~14708 (1990)
123. Boone DL, "The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses", Nat Immunol, 5, pp.1052~1060 (2004)
124. Friedman CS, "The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response", EMBO Rep, 9, pp.930~936 (2008)
125. Hayakawa S, "ZAPS is a potent stimulator of signaling mediated by the RNA helicase RIG-I during antiviral responses", Nat Immunol, 12, pp.37~44 (2011)
126. Youn HS, "Cinnamaldehyde suppresses toll-like receptor 4 activation mediated through the inhibition of receptor oligomerization", BIOCHEMICAL PHARMACOLOGY, 75, pp.494~502 (2008), PERGAMON-ELSEVIER SCIENCE LTD
127. Youn HS, "Sulforaphane Suppresses Oligomerization of TLR4 in a Thiol-Dependent Manner", JOURNAL OF IMMUNOLOGY, 184(1), pp.411~419 (2010), AMER ASSOC IMMUNOLOGISTS
128. Youn HS, "Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex", J Immunol, 175, pp.3339~3346 (2005)
129. Youn HS, "Suppression of MyD88- and TRIF-dependent signaling pathways of toll-like receptor by (-)-epigallocatechin-3-gallate, a polyphenol component of green tea", BIOCHEMICAL PHARMACOLOGY, 72, pp.850~859 (2006), PERGAMON-ELSEVIER SCIENCE LTD
130. Lee JK, "Suppression of the TRIF-dependent signaling pathway of Toll-like receptors by luteolin", Biochem Pharmacol, 77, pp.1391~1400 (2009)
131. Mancek-Keber M, "Free thiol group of MD-2 as the target for inhibition of the lipopolysaccharide-induced cell activation", J Biol Chem, 284, pp.19493~19500 (2009)
132. Hornung V, "AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC", Nature, 458, pp.514~518 (2009)
133. Unterholzner L, "IFI16 is an innate immune sensor for intracellular DNA", Nat Immunol, 11, pp.997~1004 (2010)
134. Yang P, "The cytosolic nucleic acid sensor LRRFIP1 mediates the production of type I interferon via a beta-catenin-dependent pathway", Nat Immunol, 11, pp.487~494 (2010)
135. Stetson DB, "Trex1 prevents cell-intrinsic initiation of autoimmunity", Cell, 134, pp.587~598 (2008)
136. Masters SL, "Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes", Nat Immunol, 11, pp.897~904 (2010)
137. Hennessy EJ, "Targeting Toll-like receptors: emerging therapeutics", Nat Rev Drug Discov, 9, pp.293~307 (2010)

관련 논문AI추천